Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects

Ann Allergy Asthma Immunol. 1996 May;76(5):476. doi: 10.1016/S1081-1206(10)63468-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Astemizole / adverse effects*
  • Butyrophenones / adverse effects*
  • Electrocardiography / drug effects*
  • Guinea Pigs
  • Histamine H1 Antagonists / adverse effects*
  • Models, Biological
  • Piperidines / adverse effects*
  • Terfenadine / adverse effects*

Substances

  • Butyrophenones
  • Histamine H1 Antagonists
  • Piperidines
  • Terfenadine
  • Astemizole
  • ebastine